Management of Intravesical Bacillus Calmette-Guérin Failure

In this section, BCG has served as the standard treatment for many years in the treatment of non-muscle-invasive bladder cancers. Intravesical BCG has been shown to reduce the risk of tumor recurrence in intermediate- and high-risk NMIBC patients. It is widely accepted that BCG is associated with few side effects and that patients undergoing treatment [...]